U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H9NO
Molecular Weight 123.1525
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 2-(2-PYRIDYL)ETHANOL

SMILES

OCCC1=NC=CC=C1

InChI

InChIKey=BXGYBSJAZFGIPX-UHFFFAOYSA-N
InChI=1S/C7H9NO/c9-6-4-7-3-1-2-5-8-7/h1-3,5,9H,4,6H2

HIDE SMILES / InChI

Molecular Formula C7H9NO
Molecular Weight 123.1525
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents.
2001 Apr
[[Separation of oxetacaine and its metabolites] ].
2001 Jan
Biphasic effects of oxethazaine, a topical anesthetic, on the intracellular Ca(2+) concentration of PC12 cells.
2002 Aug 15
Quantum tunneling of magnetization in a new [Mn18]2+ single-molecule magnet with s = 13.
2002 Aug 21
Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol.
2003 Sep 15
Large spin differences in structurally related Fe6 molecular clusters and their magnetostructural explanation.
2004 Sep 6
Single-molecule magnets: structure and properties of [Mn18O14(O2CMe)18(hep)4(hepH)2(H2O)2](ClO4)2 with spin S = 13.
2005 Feb 7
Mechanisms involved in the contraction of intrahepatic portal vein branches by clomipramine and oxethazaine in isolated perfused rat livers.
2005 Jun
Exploration of orally available calpain inhibitors. Part 3: Dipeptidyl alpha-ketoamide derivatives containing pyridine moiety.
2006 Aug 15
Intrahepatic flow disturbance: possibility of a hidden cause of drug toxicity.
2006 Mar
Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.
2007 Apr
Vapor-diffusion-mediated single crystal-to-single crystal transformation of a discrete dimeric copper(II) complex to a discrete tetrameric copper(II) complex.
2009 Jun 1
Oxethazaine as the source of mephentermine and phentermine in athlete's urine.
2009 Mar 10
2,2'-Diamino-N,N'-(o-phenyl-ene)di-benz-amide.
2009 Mar 25
Bis(dicyanamido-κN)bis-[2-(2-hydroxy-ethyl)pyridine-κN,O]nickel(II).
2009 Nov 7
Family of Mn(III)(2)Ln(2)(mu(4)-O) compounds: syntheses, structures, and magnetic properties.
2010 Jun 7
Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis.
2010 Mar
Bis[2-(pyridin-2-yl)ethanol-κN,O]bis-(thio-cyanato-κN)nickel(II).
2010 Nov 17
Nuclearity of nickel and mixed sodium-nickel complexes: dependence on the spacer in chelating pyridine-alcoholate ligands.
2010 Sep 21
Patents
Substance Class Chemical
Created
by admin
on Thu Jul 06 13:37:28 UTC 2023
Edited
by admin
on Thu Jul 06 13:37:28 UTC 2023
Record UNII
4G94J9B8JR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
2-(2-PYRIDYL)ETHANOL
Systematic Name English
2-(2-PYRIDINYL)ETHANOL
Systematic Name English
2-PYRIDINEETHANOL
Systematic Name English
2-(2-PYRIDYL)ETHYL ALCOHOL
Systematic Name English
2-(PYRIDIN-2-YL)ETHANOL
Systematic Name English
2-(.ALPHA.-PYRIDYL)ETHANOL
Common Name English
.BETA.-(2-PYRIDYL)ETHANOL
Systematic Name English
2-(2-HYDROXYETHYL)PYRIDINE
Systematic Name English
NSC-77979
Code English
2-(2-HYDROXYETHYL) PYRIDINE
Common Name English
NSC-2144
Code English
2-PYRIDYLETHANOL
Systematic Name English
2-(.BETA.-HYDROXYETHYL)PYRIDINE [HSDB]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID2044767
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
NSC
77979
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
CAS
103-74-2
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
ECHA (EC/EINECS)
203-140-2
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
NSC
2144
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
FDA UNII
4G94J9B8JR
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
PUBCHEM
7675
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
HSDB
5357
Created by admin on Thu Jul 06 13:37:28 UTC 2023 , Edited by admin on Thu Jul 06 13:37:28 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP